All questions
Dosing and administration: Darzalex (daratumumab) in multiple myeloma 18 questions · 5 sources
Questions that apply to every indication of Darzalex are on Darzalex (daratumumab), all indications .
IV vs subcutaneous What is the difference between Darzalex IV and Darzalex Faspro? Note: The first two passages are from the Dosing and Administration Guide that the Darzalex HCP site links; the last two are from the DARZALEX FASPRO and DARZALEX Prescribing Information.
How long does a Darzalex infusion or Darzalex Faspro injection take? Is Darzalex Faspro as effective as Darzalex IV (COLUMBA)? Applies to Relapsed or refractory multiple myeloma after at least 3 prior lines: DARZALEX FASPRO vs intravenous DARZALEX monotherapy (COLUMBA)
“The efficacy of DARZALEX FASPRO as monotherapy was evaluated in
COLUMBA (NCT03277105), an open-label, randomized, non-inferiority study.
Eligible patients were required to have relapsed or refractory multiple myeloma
who had received at least 3 prior lines of therapy including a proteasome
inhibitor and an immunomodulatory agent or who were double-refractory
to a proteasome inhibitor and an immunomodulatory agent. Patients were
randomized to receive DARZALEX FASPRO 1,800 mg/30,000 units administered
subcutaneously or daratumumab 16 mg/kg administered intravenously; each
administered once weekly from weeks 1 to 8, once every 2 weeks from weeks
9 to 24 and once every 4 weeks starting with week 25 until unacceptable
toxicity or disease progression. The major efficacy outcome measures were
ORR by the IMWG response criteria and maximum Ctrough at pre-dose Cycle 3
Day 1 [see Clinical Pharmacology (12.3)]. Randomization was stratified by body
weight, myeloma type, and number of prior lines of therapy.
A total of 522 patients were randomized: 263 to the DARZALEX FASPRO arm
and 259 to the intravenous daratumumab arm. The median age was 67 years
(range: 33 to 92 years); 55% were male; and 78% were White, 14% Asian,
and 3% Black or African American. The median weight was 73 kg (range: 29
to 138). Patients had received a median of 4 prior lines of therapy. A total of
51% of patients had a prior ASCT; 100% of patients received both a PI and an
immunomodulatory agent. Forty-nine percent of patients were refractory both
a PI and an immunomodulatory agent. Eighty-two percent of patients were
refractory to their last line of prior systemic therapy.” (opens the source at this quote in a new tab) Copy Flag
Note: COLUMBA enrolled patients with relapsed or refractory multiple myeloma. Table 34 columns are DARZALEX FASPRO (N=263) and intravenous daratumumab (N=259), in that order.
Can patients switch from Darzalex IV to Darzalex Faspro? Note: This statement is from the Dosing and Administration Guide that the Darzalex HCP site links.
Dosing How long is Darzalex Faspro given for high-risk smoldering multiple myeloma? Applies to High-risk smoldering multiple myeloma: DARZALEX FASPRO monotherapy vs active monitoring (AQUILA)
What is the dose of Darzalex Faspro? What is the dose of Darzalex IV? Can the first Darzalex infusion be split over two days? What is the Darzalex dosing schedule with lenalidomide and dexamethasone (DRd)? Applies to Newly diagnosed multiple myeloma, ineligible for autologous stem cell transplant: DARZALEX + lenalidomide + dexamethasone (DRd) vs Rd (MAIA)
What is the Darzalex Faspro dosing schedule with VRd for transplant-ineligible patients? Applies to Newly diagnosed multiple myeloma, ineligible for autologous stem cell transplant: DARZALEX FASPRO + bortezomib, lenalidomide, dexamethasone (DVRd) vs VRd (CEPHEUS)
“Patients received DARZALEX FASPRO 1,800 mg/30,000 units administered
subcutaneously once weekly from weeks 1 to 6, once every three weeks from
weeks 7 to 24, and once every 4 weeks starting with week 25 until disease
progression or unacceptable toxicity. Bortezomib was administered by
subcutaneous injection at a dose of 1.3 mg/m2 body surface area twice weekly
(days 1, 4, 8, and 11) in repeated 21-day (3-week) cycles from Cycles 1-8.
Lenalidomide was administered orally at 25 mg daily on Days 1-14 of Cycles 1-8
and on Days 1-21 during Cycles 9 and beyond. Dexamethasone was administered
orally at 20 mg on Days 1, 2, 4, 5, 8, 9, 11, and 12 of Cycles 1-8 (or at 20 mg
on Days 1, 4, 8, and 11 for patients >75 years or BMI <18.5) and at 40 mg on
Days 1, 8, 15, and 22 during Cycles 9 and beyond (or at a reduced dose of 20 mg
per week for patients >75 years or BMI <18.5). On the days of DARZALEX FASPRO
injection, the dexamethasone dose was administered orally or intravenously
as a pre-injection medication.” (opens the source at this quote in a new tab) Copy Flag
What is the Darzalex Faspro dosing schedule with VRd for transplant-eligible patients? Applies to Newly diagnosed multiple myeloma, eligible for autologous stem cell transplant: DARZALEX FASPRO + VRd induction and consolidation vs VRd (PERSEUS)
“Patients received DARZALEX FASPRO 1,800 mg/30,000 units administered
subcutaneously once weekly from weeks 1 to 8 and once every 2 weeks from
weeks 9 to 16 during induction. After week 16, patients underwent stem cell
mobilization, high dose chemotherapy, and ASCT. Within 12 weeks of ASCT,
and when engraftment was complete, patients received DARZALEX FASPRO
once every 2 weeks from weeks 1 to 8 during consolidation. Bortezomib was
administered by subcutaneous injection at a dose of 1.3 mg/m2 body surface
area twice weekly for two weeks (days 1, 4, 8, and 11) of each 28-day cycle for
weeks 1-16 during induction and weeks 1-8 during consolidation. Lenalidomide
was administered orally at 25 mg daily (days 1-21) during weeks 1-16 during
induction and weeks 1-8 during consolidation. Dexamethasone (oral or
intravenous) was administered at 40 mg on Days 1-4 and Days 9-12 during
weeks 1-16 during induction and weeks 1-8 during consolidation. On the days
of DARZALEX FASPRO injection, the dexamethasone dose was administered
orally or intravenously as a pre-injection medication.” (opens the source at this quote in a new tab) Copy Flag
What if a Darzalex or Darzalex Faspro dose is missed? Premedication What premedications and post-medications are given with Darzalex Faspro? What premedications are required before a Darzalex IV infusion? Does Darzalex or Darzalex Faspro require shingles (herpes zoster) prophylaxis? Administration What are the Darzalex IV infusion rates? Note: Table 6 columns are dilution volume, initial rate (first hour), rate increment, and maximum rate.
How is Darzalex Faspro injected? How should Darzalex Faspro be stored before injection?